Mortality in HIV-infected injection drug users with active vs cleared hepatitis C virus-infection: A population-based cohort study

Journal of Viral Hepatitis

Volumn 17, Issue 4, 2010, Pages 261-268

  Omland, L H ^a   Jepsen, P ^b   Weis, N ^c   Christensen, P B ^d   Laursen, A L ^b   Nielsen, H ^e   Krarup, H ^e   Sorensen H T ^b,f   Obel, N ^a  

^a Rigshospitalet   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e AALBORG UNIVERSITY HOSPITAL   (Denmark)

^f BOSTON UNIVERSITY   (United States)

Author keywords

Epidemiology; HCV RNA; Hepatitis C virus; HIV; Mortality

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DENMARK; DISEASE COURSE; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; COHORT STUDIES; DENMARK; DRUG USERS; FEMALE; HEPATITIS C; HEPATITIS VIRUSES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; SUBSTANCE ABUSE, INTRAVENOUS; SURVIVAL ANALYSIS;

EID: 77950287228     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01175.x     Document Type: Article

References (39)

1. UNAIDS. 07 AIDS epidemic update. 2007.
2. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006 44 : S6 S9.
3. Mohsen AH, Easterbrook P, Taylor CB, Norris S. Hepatitis C and HIV-1 coinfection. Gut 2002 51 : 601 608.
4. World Health Organization. Hepatitis C - global prevalence (update). Wkly Epidemiol Rec 1999 74 : 425 427.
5. Weis N, Lindhardt BO, Kronborg G et al. Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study. Clin Infect Dis 2006 42 : 1481 1487.
6. Camma C, Di BD, Schepis F et al. Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data. Hepatology 2004 39 : 333 342.
7. Lohse N, Hansen AB, Pedersen G et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007 146 : 87 95.
8. Poynard T, McHutchison J, Manns M et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002 122 : 1303 1313.
9. Veldt BJ, Heathcote EJ, Wedemeyer H et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med 2007 147 : 677 684.
10. Benhamou Y, Bochet M, Di Martino V et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999 30 : 1054 1058.
11. Hansen AB, Gerstoft J, Kronborg G, Pedersen C, Sorensen HT, Obel N. Mortality in siblings of patients coinfected with HIV and hepatitis C virus. J Infect Dis 2007 195 : 230 235.
12. Hansen AB, Lohse N, Gerstoft J et al. Cause-specific excess mortality in siblings of patients co-infected with HIV and hepatitis C virus. PLoS ONE 2007 2 : e738.
13. Merchante N, Giron-Gonzalez JA, Gonzalez-Serrano M et al. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS 2006 20 : 49 57.
14. Puoti M, Bonacini M, Spinetti A et al. Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J Infect Dis 2001 183 : 134 137.
15. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001 345 : 41 52.
16. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006 13 : 34 41.
17. Barrett S, Goh J, Coughlan B et al. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut 2001 49 : 423 430.
18. Poynard T, Yuen MF, Ratziu V et al. Viral hepatitis C. Lancet 2003 362 : 2095 2100.
19. Rockstroh JK, Mocroft A, Reiss P et al. Does Hepatitis C Virus (HCV) Genotype or Viral Load Predict the Risk of All-Cause Mortality of HIV/HCV Coinfection? [Abstract PS8/2]. 11th European AIDS Conference (EACS), Madrid, October 2007. Available at: http://www.eacs.eu/conference/madrid07/.
20. Manns MP, Foster GR, Rockstroh JK, Zeuzem S, Zoulim F, Houghton M. The Way Forward in HCV Treatment - Finding the Right Path. Nat Rev Drug Discov 2007 6 : 991 1000.
21. Statistics Denmark: Population and elections; Population in Denmark. Available at http://statistikbanken.dk.
22. Lohse N, Hansen AB, Jensen-Fangel S et al. Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort Study. Scand J Infect Dis 2005 37 : 338 343.
23. The Central Office of Civil Registration : The Danish Civil Registration System. Available at http://www.cpr.dk/cpr/site.aspx?p = 27.
24. Obel N, Engsig FN, Rasmussen LD, Larsen MV, Omland LH, Sorensen HT Cohort profile: the Danish HIV Cohort Study. Int J Epidemiol. Epub ahead of print. PMID: 18799495. doi :.
25. Omland LH, Weis N, Skinhoj P et al. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study. HIV Med 2008 9 : 300 306.
26. Krarup HB, Drewes AM, Madsen PH. A quantitative HCV-PCR test for routine diagnostics. Scand J Clin Lab Invest 1998 58 : 415 422.
27. Frank L. Epidemiology. When an entire country is a cohort. Science 2000 287 : 2398 2399.
28. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999 46 : 263 268.
29. The National Board of Health: The Danish National Hospital Registry (In Danish). Available at http://www.sst.dk/Indberetning%20og%20statistik/ Landspatientregisteret.aspx.
30. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987 40 : 373 383.
31. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 2004 57 : 1288 1294.
32. Quan H, Sundararajan V, Halfon P et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005 43 : 1130 1139.
33. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989 79 : 340 349.
34. R Development Core Team. R: A Language and Environment for Statistical Computing. 2008. R Foundation for Statistical Computing. Available at http://www.R-project.org
35. Grebely J, Conway B, Raffa JD, Lai C, Krajden M, Tyndall MW. Hepatitis C virus reinfection in injection drug users. Hepatology 2006 44 : 1139 1145.
36. Kim AY, Schulze zur WJ, Kuntzen T et al. Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection. PLoS Med 2006 3 : e492.
37. Seeff LB, Miller RN, Rabkin CS et al. 45-Year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000 132 : 105 111.
38. Wiese M, Grungreiff K, Guthoff W, Lafrenz M, Oesen U, Porst H. Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany - a 25-year multicenter study. J Hepatol 2005 43 : 590 598.
39. Seeff LB, Hollinger FB, Alter HJ et al. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute Collaborative Study. Hepatology 2001 33 : 455 463.